Skip to content

A Study on the Interventional Effects and Mechanisms of Individual Target Transcranial Magnetic Stimulation on Daytime Symptoms of Insomnia in Young Adults

A Study on the Interventional Effects and Mechanisms of Individual Target Transcranial Magnetic Stimulation on Daytime Symptoms of Insomnia in Young Adults

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110854
Enrollment
Unknown
Registered
2025-10-21
Start date
2025-10-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Control group:Sham repeated transcranial magnetic stimulation
Trial group:Repeated transcranial magnetic stimulation

Sponsors

The First Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 24 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 24 years (inclusive), regardless of gender; 2. Meets the DSM-5 diagnostic criteria for insomnia; 3. Pittsburgh Sleep Quality Index (PSQI) score greater than 7 and less than 15, and able to comply with fMRI scanning requirements; 4. Good compliance, capable of understanding and voluntarily accepting the study protocol, with informed consent signed.

Exclusion criteria

Exclusion criteria: 1. Presence of severe somatic diseases or conditions that may affect the central nervous system (e.g., systemic diseases requiring corticosteroid use, malignancy, syphilis). 2. History of intracranial diseases, head trauma, alcohol abuse, abnormal electroencephalogram (EEG), evidence of structural brain abnormalities on MRI, or a family history of epilepsy. 3. Presence of comorbid conditions requiring priority treatment (e.g., suicidal ideation or severe mental disorders) or substance abuse (e.g., alcohol, hypnotic drugs); or uncontrolled conditions that affect sleep or require urgent intervention (e.g., obstructive sleep apnea requiring continuous positive airway pressure therapy). 4. Contraindications to MRI scanning or transcranial magnetic stimulation, such as the presence of metallic or electronic implants (e.g., intracranial metal objects, cochlear implants, cardiac pacemakers, stents), or claustrophobia. 5. Current pregnancy, lactation, or planning a pregnancy during the trial period. 6. Other circumstances deemed by the investigator as unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Fatigue Scale-14 score;Insomnia Daytime Symptoms Inventory Questionnaire-14 score;Hamilton Depression Scale score;Hamilton Anxiety Scale score;Psychomotor Vigilance Task score;Brain MRI;Small-molecule metabolic biomarkers (changes in plasma histidine and valine concentrations);Epworth Sleepiness Scale score;

Countries

China

Contacts

Public ContactCai Min

The First Affiliated Hospital of Air Force Military Medical University

mincai8787@hotmail.com+86 153 5350 8787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026